Journal article
Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled Trial
Stroke (1970), Vol.56(6), pp.1366-1375
06/2025
DOI: 10.1161/STROKEAHA.124.048899
PMID: 40151939
Abstract
We aimed to determine whether extensive severe computed tomography (CT) hypodensity, representing blood-brain barrier injury, would be associated with a reduced benefit of endovascular therapy (EVT) in patients presenting with large core stroke.
This study is an exploratory analysis of SELECT2 (Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke), a randomized controlled trial of EVT versus medical management in patients with large ischemic core who presented to 31 comprehensive stroke centers across the United States, Canada, Europe, Australia, and New Zealand. Visible CT hypodensity was outlined, and a threshold of severe CT hypodensity was defined as the lower 99% CI of contralateral thalamic gray matter in Hounsfield units (HU). The association between the volume of severe CT hypodensity and modified Rankin Scale (mRS) score of 0 to 3 was evaluated using logistic regression models, with adjustment for age, National Institutes of Health Stroke Scale, total noncontrast CT core volume, and a volume-by-treatment interaction. The relationship between severe CT hypodensity volume and the probability of an mRS score of 0 to 3 was used to select clinically relevant volume cut points for further evaluation. The treatment effect of EVT versus medical management on independent ambulation and hemicraniectomy was assessed in 2 subgroups based on these volume cut points.
In 322 patients, the median CT density was 31 HU (interquartile range, 28-34). The selected threshold of severe CT hypodensity was 26 HU. The volume of ischemic core ≤26 HU (per 1 mL increase) was associated with lower odds of mRS score of 0 to 3 after EVT (adjusted odds ratio [aOR], 0.96 [95% CI, 0.94-0.99]), but not medical management (aOR, 1.01 [95% CI, 0.98-1.03];
interaction<0.01). In 101 patients with ≥26 mL of severe CT hypodensity, EVT, compared with medical management, was not associated with mRS score of 0 to 3 (aOR, 0.98 [95% CI, 0.33-2.88]) and was associated with hemicraniectomy (≥26 mL: aOR, 3.45 [95% CI, 1.09-10.86] versus <26 mL: aOR, 0.74 [95% CI, 0.31-1.75];
interaction=0.03), whereas among 221 patients with <26 mL of severe hypodensity EVT was associated with mRS score of 0 to 3 (aOR, 7.20 [95% CI, 3.55-15.47];
interaction<0.01).
Severe hypodensity within large ischemic regions modifies the thrombectomy treatment effect and increases the likelihood of hemicraniectomy, independent of lesion volume.
URL: https://www.clinicaltrials.gov; Unique identifier: NCT03876457.
Details
- Title: Subtitle
- Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled Trial
- Creators
- Vignan Yogendrakumar - The Royal Melbourne HospitalBruce C V Campbell - The University of MelbourneHannah Johns - The University of MelbourneLeonid Churilov - The University of MelbourneFelix C Ng - The Royal Melbourne HospitalClark W Sitton - The University of Texas Health Science Center at HoustonAmeer E Hassan - Valley Baptist Medical CenterMichael G Abraham - University of Kansas Medical CenterSantiago Ortega-Gutierrez - University of IowaM Shazam Hussain - Cleveland ClinicMichael Chen - Rush University Medical CenterScott E Kasner - University of PennsylvaniaGagan Sharma - The University of MelbourneProdipta Guha - The Royal Melbourne HospitalDeep K Pujara - Case Western Reserve UniversityFaris Shaker - University of Kansas Medical CenterMaarten G Lansberg - Stanford UniversityLawrence R Wechsler - Hospital of the University of PennsylvaniaThanh N Nguyen - Boston Medical CenterJohanna T Fifi - Icahn School of Medicine at Mount SinaiMichael D Hill - University of CalgaryMarc Ribo - Vall d'Hebron Hospital UniversitariMark W Parsons - University of Newcastle AustraliaStephen M Davis - The Royal Melbourne HospitalJames C Grotta - Memorial HermannGregory W Albers - Stanford UniversityAmrou Sarraj - Case Western Reserve UniversitySELECT2 Investigators
- Resource Type
- Journal article
- Publication Details
- Stroke (1970), Vol.56(6), pp.1366-1375
- DOI
- 10.1161/STROKEAHA.124.048899
- PMID
- 40151939
- NLM abbreviation
- Stroke
- ISSN
- 1524-4628
- eISSN
- 1524-4628
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Grant note
- Stryker NeurovascularTier 2 Canada Research ChairUniversity of Ottawa Department of Medicine New Investigator Chair
The SELECT2 trial (Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke) was funded by Stryker Neurovascular. This study received no specific funding. Dr Yogendrakumar is supported by a Tier 2 Canada Research Chair and a University of Ottawa Department of Medicine New Investigator Chair.
- Language
- English
- Electronic publication date
- 03/28/2025
- Date published
- 06/2025
- Academic Unit
- Neurology; Radiology; Iowa Neuroscience Institute; Neurosurgery
- Record Identifier
- 9984802102802771
Metrics
9 Record Views